Program Description

The NYU Cancer Institute, one of 61 NCI-funded cancer centers nationwide, is a multidisciplinary matrix cancer center with state-of-the-art patient care and robust programs in basic, translational and clinical research. Established basic research programs include Cancer Epidemiology, Cancer Immunology, Cancer Neurobiology, Molecular Carcinogenesis, Cellular Growth Control and Stem Cell Biology. Disease-specific programs include those focused on breast, gastrointestinal, genitourinary, gynecologic, lung and neurological and skin cancers. The Cancer Institute maintains a Translational Research Task Force to foster synergies between basic and clinical investigators. The Cancer Institute also maintains a comprehensive repertoire of core facilities.

Under the leadership of Steven Burakoff, M.D., the NYU Cancer Institute is in the midst of an unprecedented expansion. New outpatient clinical facilities have been established including an 85,000 sq. ft. Clinical Center located on 34th Street in Midtown Manhattan that opened in August 2004. Our already strong basic research enterprise has been enhanced with renovated laboratory space and prominent new faculty recruits. Three floors of research laboratories in the Smilow Research Center have been assigned to the NYU Cancer Institute. A key element in our historic growth agenda will be the staffing of these laboratories with new faculty working in the area of cancer.

Recruitment for the program is led by Mark Philips, M.D., Deputy Director for Basic Research and Steven Burakoff, M.D., Director of the Cancer Institute..